NIH Medline Plus discusses the results of the SPARKS trial.   Brigham Health's Vital Lines recently featured an OAPol model study examining the lower utilization rates of total knee replacement among racial and ethnic minorities.

Publications Losina E, Usiskin IM, Smith SR, Sullivan JK, Smith KC, Hunter DJ, Messier SP, Paltiel AD, Katz JN. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: A model-based evaluation. Osteoarthritis Cartilage. 2018 Feb 23. PMID: 29481917. Collins JE. What can our hands tell us about the future of our knees? Arthritis Rheumatol. 2018 Feb 22. PMID: 29471592. Losina E, Katz JN. Hydroxychloroquine: another battle lost in…